Description

Indication & Scope

Lumigan® is a prescription prostaglandin analog indicated for the reduction of elevated intraocular pressure in patients with open-angle glaucoma or ocular hypertension. It may be used as monotherapy or in combination with other intraocular pressure-lowering medications.

Mechanism: Bimatoprost is a synthetic prostamide (prostaglandin F₂α analog) that lowers intraocular pressure by increasing aqueous humor outflow through the uveoscleral pathway and, to a lesser extent, the trabecular meshwork.
Drug class: Prostaglandin analog (Antiglaucoma agent)
Clinical use: Reduction of elevated intraocular pressure in patients with open-angle glaucoma or ocular hypertension.

Specification

Generic Name	Bimatoprost Ophthalmic Solution
Brand Name	Lumigan®
Ingredient	Bimatoprost
Dosage Form	Eye Drops
Package	3 mL: 0.9 mg (0.03%)/bottle
Conditions Treated	Open-angle glaucoma; Ocular hypertension
Taboos	Hypersensitivity to bimatoprost or any component of the product
Place of origin	Ireland
Prescription type	Prescription Drug (Rx)
Storage Conditions	Store at 2–25°C, protected from light. Keep the container tightly closed.
Manufacturer	Allergan Pharmaceuticals Ireland
Registration Authority	National Medical Products Administration (NMPA), China
Approval number	HJ20150484
Date of Revision	February 17, 2025
Shelf Life	24 months

How to use ?

Recommended Dose: Instill one drop into the affected eye(s) once daily in the evening.

Time: Administer once every evening. Do not exceed one dose per day, as more frequent administration may reduce the intraocular pressure-lowering effect.

Instructions for use: For ophthalmic use only. Remove soft contact lenses before instillation and wait at least 15 minutes before reinsertion. If using other topical ophthalmic medications, allow an interval of at least 5 minutes between applications.

Interaction: No clinically significant systemic drug interactions have been identified. When used with other ophthalmic products, administer each medication separately with an appropriate interval.

Side effects: Common adverse reactions include conjunctival hyperemia, ocular pruritus, eye irritation, burning sensation, dry eye, foreign body sensation, tearing, eyelash growth, iris pigmentation changes, periocular skin pigmentation, headache, and dizziness.

Important Notice

This product should be administered only by qualified healthcare professionals in accordance with the approved prescribing information and local clinical guidelines. Dosage and administration may vary depending on patient condition, indication, and regional regulatory requirements.

Packaging & Shipping

Packaging

Original manufacturer’s packaging with secure export carton. Customized export packaging is available upon request.

Shipping Methods

Express Courier (EMS, DHL, FedEx, UPS), Air Freight, and Sea Freight. Cold-chain transportation is available for products requiring temperature-controlled logistics.

Export Support

Certificate of Analysis

GMP Certificate

Commercial Invoice

Packing List & CPP

Cold Chain Logistics

Customs Documentation

Scientific and regulatory sources

1.WHO References

2.NMPA

3.FDA

4.EMA

FAQ

What is Lumigan® used for?

Lumigan® is used to reduce elevated intraocular pressure in patients with open-angle glaucoma or ocular hypertension, helping lower the risk of optic nerve damage and vision loss.

How often should Lumigan® be used?

The recommended dosage is one drop once daily in the evening. Using it more than once daily is not recommended.

Can I wear contact lenses while using Lumigan®?

Yes, but soft contact lenses should be removed before applying the eye drops and reinserted 15 minutes after administration.

Can Lumigan® change eye color?

Long-term treatment may gradually increase brown pigmentation of the iris and darken the eyelid skin. Eyelashes may also become longer, thicker, and darker.